| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $120.9M | $116.1M | $142.9M |
| YoY Revenue Growth % | +4.1% | -18.8% | — |
| Gross Profit | $85.9M | $74.4M | — |
| Gross Margin % | 71.0% | 64.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.0M | -$50.8M | -$190.4M |
| Operating Margin % | -6.6% | -43.8% | -80.0% |
| Net Income (GAAP) | -$12.7M | -$79.4M | -$180.4M |
| EBITDA (Normalized) | -$7.2M | -$49.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $18.0K | -$19.1M | -$43.3M |
| Capital Expenditures (CapEx) | $1.0M | $2.3M | — |
| Free Cash Flow (FCF) | -$1.0M | -$21.4M | -$43.3M |
| FCF Margin % | -0.8% | -18.4% | -30.3% |
| Return on Invested Capital (ROIC %) | -4.1% | -29.2% | — |
| Cash & Short-Term Equivalents | $37.8M | $30.9M | — |
| Total Debt (Short + Long Term) | $172.6M | $176.2M | — |
| Total Stockholders' Equity | $18.4M | -$7.7M | — |